Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	69.56	-311.51	-1023.35
Graham Fair Price	47.52	15.29	10.36
PEG	2107.48	-0.24	0.01
Price/Book	-3.79	4.10	4.26
Price/Cash Flow	-72.34	-107.03	386.95
Prices/Earnings	56.74	-29.12	-67.31
Price/Sales	-2.77	20.14	20.71
Price/FCF	-72.34	-107.03	386.95
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-0.16	0.73	0.73
Operating Margin	-59.58	-0.17	-0.10
ROA	-124.79	-0.02	< 0.005
ROE	-0.02	-0.04	-122.39
ROIC	-0.01	-0.02	-62.19
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	0.03	-99.31
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-10.91	-0.57	94.75
EPS QOQ	-62.36	-1.22	98.04
FCF QOQ	42.92	-4.46	-89.60
Revenue QOQ	0.03	-0.01	-50.98
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	66.77	68.01	1.85
Days Sales Outstanding (DSO)	28.33	33.96	19.89
Inventory Turnover	1.35	1.32	-1.81
Debt/Capitalization	0.45	0.45	0.23
Quick Ratio	1.91	1.30	-31.66
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	17.37	17.18	-1.08
Cash	4.29	3.58	-16.71
Capex	-0.19	-0.21	-7.08
Free Cash Flow	0.19	-0.66	244.09
Revenue	3.57	3.50	-2.12
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.32	1.64	-29.53
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-129.97	-45.71	64.83
Naive Interpretation	Member

06 - Financial Health · Weak

Rating